| Ipsenâs Decapeptyl® 6-Month Formulation Receives... |
|
Regulatory News: Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities (Agence Française de... More »
|
|
Genetic Engineering News - Nov. 12, 2009
|
| Ipsen Gets Marketing Authorization For 6-month... |
|
(RTTNews) - Ipsen (IPRMF.PK: News ) announced that the French regulatory authorities have granted the marketing authorization to the 6-month sustained-release formulation of... More »
|
|
RTTNews.com - Nov. 12, 2009
|
| Ipsen`s Decapeptyl® 6-Month Formulation Receives Marketing... |
|
PARIS--(Business Wire)-- Regulatory News: Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities... More »
|
|
Reuters - Nov. 12, 2009
|
| Ipsen’s Decapeptyl® 6-Month Formulation Receives Marketing... |
|
Regulatory News. Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities (Agence Française de Sécurité... More »
|
|
PR inside - Nov. 12, 2009
|
| Ipsen receives marketing authorization in France for its... |
|
Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities (Agence Française de Sécurité Sanitaire des... More »
|
|
News-Medical.Net - Nov. 12, 2009
|
| Ipsen's Decapeptyl(R) 6-Month Formulation Receives... |
|
Regulatory News: Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities (Agence Francaise de Securite... More »
|
|
Individual.com - Nov. 12, 2009
|
| Ipsen's Decapeptyl® 6-Month Formulation Receives Marketing... |
|
PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN - News), an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities... More »
|
|
Business Wire via Yahoo! - Nov. 12, 2009
|